This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
ID Biomedical shifts surplus flu vaccine to Canada
ID Biomedical, Canada’s main flu vaccine supplier, will sell its remaining surplus doses in Canada rather than the United States. CEO Dr. Tony Holler said the U.S. move would not aid accelerating licensing, despite a multiyear U.S. contract for Fluviral doses once approved. Officials noted ongoing U.S. discussions for potential vaccine import, with Canada currently facing a shortage and uncertainty over how doses will be allocated between government programs and the private market.
MENTIONED IN THIS ARTICLE
Montreal
ID Biomedical
Canada
United States
Tony Holler
Holler
Thesday
U.S
Stoller
10 Biomedical
Seattle Times
Todd Patrick
D Biomedical
Heller
Pauick
Aventis
Bio
Moller
Biomedical Corp
Burnaby
B.C